Ernesto Zatarain Rios, MD
Rheumatology · Burlingame
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 9
- 1 carrier
- Offices
- 4
Offices
4 locations · Sutter Bay Medical Foundation · 3,783 clinicians in this group
Looking this up.
Hospitals listed: Mills-Peninsula Medical Center. That is not proof they admit you there this week.
Plans that list them
9 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Rios’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence A46442 · Current
Licensed to practise in California · since 1989 · expires 2027-07-31 · Autonomous University of Chihuahua Faculty of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Peninsula Medical CenterBurlingame, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 4 of 5 · 78% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.139, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.242, Oct 2024 – Sep 2025
See every measure and the patient survey for Peninsula Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.139 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.242 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.21 (0.27 to 2.15) · 1,258 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.81 (0.51 to 1.1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 155.44 (112.67 to 198.21) · 90 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.5 · 32 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 82 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10 · 188 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9 · 473 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.8 · 342 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.4 · 485 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.9 · 3,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.2 (0 to 0.4) · 6,904 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.21 (0.02 to 0.4) · 7,052 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.41 (1.43 to 5.39) · 1,695 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.72 (0.17 to 3.28) · 665 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.66 to 3.56) · 1,545 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.1 (1.3 to 12.9) · 670 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.96 (2.63 to 9.29) · 653 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.61 (0.15 to 3.08) · 418 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.14 (0 to 0.78) · 5,539 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.7 · 192 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.215 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.263 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.74 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.3 · 300 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19 · 702 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 1.2 · 207 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -13.6 · 531 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 24.3 · 343 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.1 · 449 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 4.5 (2.8 to 7) · 85 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 9.6 (6.7 to 13.7) · 85 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.7 · 189 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11 · 45 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.6 · 117 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13 (9.7 to 17.2) · 584 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.2) · 764 cases | No different | Jan 2024 – Dec 2024 |
What patients said (523 patients answered, 27% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 76% |
| Nurses "always" communicated well | 81% |
| Doctors "always" communicated well | 80% |
| Staff "always" explained | 58% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 79% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 75% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 54% |
| "YES", patients would definitely recommend the hospital | 78% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$61,751
Medicare paid this office $61,751 for 258 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 202 | $37,990 | $111 |
| Long return visit (40+ min) | 37 | $6,117 | $146 |
| New patient visit (60+ min) | 31 | $5,837 | $188 |
| Short return visit (20+ min) | 29 | $2,690 | $82 |
| Aspiration and/or injection of fluid from large joint | 28 | $2,534 | $70 |
See all 9 services
| Return visit (30+ min) | 202 | $37,990 | $111 |
| Long return visit (40+ min) | 37 | $6,117 | $146 |
| New patient visit (60+ min) | 31 | $5,837 | $188 |
| Short return visit (20+ min) | 29 | $2,690 | $82 |
| Aspiration and/or injection of fluid from large joint | 28 | $2,534 | $70 |
| New patient visit (45+ min) | 12 | $1,899 | $158 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 71 | $1,205 | $15 |
| Injection, methylprednisolone acetate, 1 mg | 23 | $88 | None |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 13 | $42 | None |
Who their Medicare patients are
258 Original Medicare patients in 2024. Average age 76 · Women 80% · Also on Medicaid 5% · Health risk score 1.22. At or below the middle of the specialty; the typical rheumatology clinician is at 1.38.
Conditions among them: High blood pressure 64% · Coronary heart disease 23% · Diabetes 22% · Chronic kidney disease 22% · Heart failure 16% · Atrial fibrillation 16% · Depression 15% · Cancer 12% · COPD 12% · Dementia 5% · Stroke 5%.
The office billed $220,644, Medicare allowed $85,037 and paid $61,751; for 1,563 services of 23 kinds; $187 of it was for drugs given in the office and $61,564 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 258 | 1,563 | 76 | 1.22 | $220,644 | $61,751 |
| 2023 | 282 | 738 | 76 | 1.21 | $235,894 | $70,090 |
| 2022 | 231 | 484 | 76 | 1.29 | $172,076 | $51,606 |
| 2021 | 280 | 631 | 75 | 1.23 | $204,534 | $64,613 |
| 2020 | 230 | 638 | 76 | 1.38 | $193,715 | $55,160 |
| 2019 | 281 | 743 | 75 | 1.34 | $247,379 | $70,258 |
| 2018 | 264 | 1,673 | 76 | 1.28 | $277,076 | $77,452 |
| 2017 | 283 | 838 | 74 | 1.21 | $241,628 | $69,407 |
| 2016 | 620 | 1,187 | 75 | 1.03 | $271,143 | $76,362 |
| 2015 | 769 | 1,286 | 74 | 0.94 | $249,058 | $73,963 |
| 2014 | 782 | 1,342 | 75 | 0.91 | $202,139 | $56,137 |
| 2013 | 1,195 | 1,868 | 74 | 0.86 | $198,012 | $61,725 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 10 services
| Return visit (30+ min) | 200 | $37,597 | $113 |
| New patient visit (60+ min) | 54 | $11,021 | $204 |
| Long return visit (40+ min) | 48 | $8,896 | $151 |
| Short return visit (20+ min) | 29 | $2,941 | $79 |
| Aspiration and/or injection of fluid from large joint | 33 | $2,772 | $69 |
| New patient visit (45+ min) | 15 | $2,372 | $158 |
| Aspiration and/or injection of fluid from small joint | 12 | $751 | $47 |
| Injection, methylprednisolone acetate, 40 mg | 26 | $198 | None |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 21 | $76 | None |
| Injection, methylprednisolone acetate, 20 mg | 12 | $57 | None |
2022: 6 services
| Return visit (30+ min) | 169 | $28,820 | $107 |
| Long return visit (40+ min) | 42 | $8,568 | $165 |
| New patient visit (60+ min) | 26 | $5,354 | $206 |
| New patient visit (45+ min) | 20 | $3,004 | $150 |
| Aspiration and/or injection of fluid from large joint | 17 | $1,401 | $70 |
| Injection, methylprednisolone acetate, 40 mg | 33 | $227 | None |
2021: 7 services
| Return visit (30+ min) | 208 | $40,401 | $112 |
| New patient visit (45+ min) | 45 | $6,619 | $147 |
| New patient visit (60+ min) | 26 | $5,426 | $209 |
| Long return visit (40+ min) | 23 | $4,729 | $169 |
| Short return visit (20+ min) | 25 | $2,679 | $81 |
| Aspiration and/or injection of fluid from large joint | 21 | $1,547 | $59 |
| Injection, methylprednisolone acetate, 40 mg | 37 | $230 | None |
2020: 9 services
| Return visit (30+ min) | 179 | $29,155 | $91 |
| New patient visit (60+ min) | 41 | $7,806 | $190 |
| New patient visit (45+ min) | 30 | $4,755 | $159 |
| Long return visit (40+ min) | 26 | $4,546 | $134 |
| Aspiration and/or injection of fluid from large joint | 25 | $2,165 | $56 |
| Short return visit (20+ min) | 24 | $1,695 | $61 |
| Telephone medical discussion with physician, 21-30 minutes | 11 | $1,135 | $103 |
| Telephone medical discussion with physician, 11-20 minutes | 13 | $1,022 | $73 |
| Injection, methylprednisolone acetate, 40 mg | 35 | $266 | None |
2019: 9 services
| Return visit (30+ min) | 194 | $34,061 | $96 |
| New patient visit (60+ min) | 84 | $15,190 | $181 |
| Long return visit (40+ min) | 55 | $9,816 | $127 |
| Aspiration and/or injection of fluid from large joint | 31 | $2,631 | $47 |
| Short return visit (20+ min) | 27 | $2,450 | $68 |
| New patient visit (45+ min) | 15 | $2,305 | $154 |
| Aspiration and/or injection of fluid from small joint | 13 | $824 | $39 |
| Injection, methylprednisolone acetate, 40 mg | 28 | $225 | None |
| Injection, methylprednisolone acetate, 20 mg | 17 | $59 | None |
2018: 11 services
| Return visit (30+ min) | 178 | $32,157 | $90 |
| Injection, denosumab, 1 mg | 15 | $12,760 | None |
| New patient visit (60+ min) | 66 | $10,934 | $166 |
| Long return visit (40+ min) | 47 | $8,188 | $124 |
| New patient visit (45+ min) | 25 | $3,635 | $145 |
| Aspiration and/or injection of fluid from large joint | 41 | $3,105 | $51 |
| Short return visit (20+ min) | 26 | $2,165 | $62 |
| Aspiration and/or injection of fluid from small joint | 19 | $1,390 | $34 |
| Injection of drug or substance under skin or into muscle | 16 | $324 | $20 |
| Injection, methylprednisolone acetate, 40 mg | 34 | $244 | None |
| Injection, methylprednisolone acetate, 20 mg | 25 | $113 | None |
2017: 11 services
| Return visit (30+ min) | 180 | $34,188 | $92 |
| New patient visit (60+ min) | 75 | $13,260 | $177 |
| Long return visit (40+ min) | 56 | $10,433 | $123 |
| Aspiration and/or injection of fluid from large joint | 35 | $3,561 | $59 |
| Short return visit (20+ min) | 26 | $2,299 | $61 |
| New patient visit (45+ min) | 17 | $2,143 | $126 |
| Aspiration and/or injection of fluid from small joint | 13 | $749 | $42 |
| Aspiration and/or injection of fluid from medium joint | 11 | $552 | $50 |
| Dxa bone density measurement of hip, pelvis, spine | 35 | $403 | $12 |
| Injection, methylprednisolone acetate, 40 mg | 38 | $294 | None |
| Injection, methylprednisolone acetate, 20 mg | 23 | $88 | None |
2016: 11 services
| Return visit (30+ min) | 169 | $28,728 | $90 |
| New patient visit (60+ min) | 68 | $12,213 | $180 |
| Long return visit (40+ min) | 69 | $10,450 | $127 |
| Dxa bone density measurement of hip, pelvis, spine | 148 | $7,862 | $53 |
| New patient visit (45+ min) | 31 | $4,433 | $143 |
| Dxa bone density measurement of hip, pelvis, spine | 241 | $2,781 | $12 |
| Aspiration and/or injection of fluid from large joint | 30 | $2,777 | $60 |
| Short return visit (20+ min) | 35 | $2,746 | $64 |
| Aspiration and/or injection of fluid from small joint | 12 | $614 | $47 |
| Injection, methylprednisolone acetate, 40 mg | 36 | $233 | None |
| Injection, methylprednisolone acetate, 80 mg | 14 | $116 | None |
2015: 10 services
| Return visit (30+ min) | 157 | $31,986 | $99 |
| New patient visit (45+ min) | 58 | $9,240 | $159 |
| Dxa bone density measurement of hip, pelvis, spine | 165 | $9,207 | $56 |
| Short return visit (20+ min) | 63 | $5,623 | $62 |
| Long return visit (40+ min) | 30 | $5,138 | $143 |
| Dxa bone density measurement of hip, pelvis, spine | 415 | $5,021 | $12 |
| Aspiration and/or injection of fluid from large joint | 24 | $2,346 | $67 |
| Aspiration and/or injection of fluid from small joint | 17 | $957 | $43 |
| Injection, methylprednisolone acetate, 40 mg | 32 | $161 | None |
| Injection, methylprednisolone acetate, 20 mg | 13 | $38 | None |
2014: 9 services
| Return visit (30+ min) | 156 | $28,215 | $91 |
| New patient visit (45+ min) | 49 | $7,005 | $143 |
| Dxa bone density measurement of hip, pelvis, spine | 606 | $6,990 | $12 |
| Short return visit (20+ min) | 50 | $3,569 | $64 |
| Aspiration and/or injection of fluid from large joint | 33 | $2,959 | $49 |
| Long return visit (40+ min) | 11 | $1,680 | $129 |
| New patient visit (30+ min) | 16 | $1,480 | $92 |
| Aspiration and/or injection of fluid from medium joint | 18 | $854 | $36 |
| Injection, methylprednisolone acetate, 40 mg | 46 | $219 | None |
2013: 11 services
| Return visit (30+ min) | 130 | $24,891 | $93 |
| Dxa bone density measurement of hip, pelvis, spine | 807 | $9,352 | $11 |
| New patient visit (45+ min) | 40 | $5,687 | $142 |
| New patient visit (60+ min) | 26 | $4,520 | $174 |
| Long return visit (40+ min) | 35 | $4,401 | $122 |
| Aspiration and/or injection of fluid from large joint | 37 | $2,981 | $49 |
| Dxa bone density measurement of hip, pelvis, spine | 244 | $2,827 | $12 |
| Short return visit (20+ min) | 33 | $2,792 | $66 |
| New patient visit (30+ min) | 12 | $1,212 | $101 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 22 | $186 | None |
| Injection, methylprednisolone acetate, 40 mg | 15 | $66 | None |
Drugs they prescribed that Part D paid
$2,193,608
Pharmacies billed $2,193,608 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 4% of their Part D prescriptions (49 of 1,412) in 2024. Above the middle of the specialty; the typical rheumatology clinician is at 3%.
1,167 generic and fewer than 11 brand-name prescriptions · $2,193,608 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Humira(Cf) | 98 | $1,113,148 | $11,359 |
| Rinvoq | 15 | $209,784 | $13,986 |
| Taltz | 16 | $169,022 | $10,564 |
| Cosentyx Sensoready | 11 | $151,637 | $13,785 |
| Forteo | 25 | $112,378 | $4,495 |
See all 27 drugs
| Humira(Cf) | 98 | $1,113,148 | $11,359 |
| Rinvoq | 15 | $209,784 | $13,986 |
| Taltz | 16 | $169,022 | $10,564 |
| Cosentyx Sensoready | 11 | $151,637 | $13,785 |
| Forteo | 25 | $112,378 | $4,495 |
| Enbrel | 14 | $107,358 | $7,668 |
| Simponi | 12 | $68,995 | $5,750 |
| Teriparatide | 14 | $28,584 | $2,042 |
| Hydroxychloroquine Sulfate | 227 | $10,820 | $48 |
| Febuxostat | 23 | $3,170 | $138 |
| Methotrexate | 131 | $3,117 | $24 |
| Leflunomide | 35 | $2,458 | $70 |
| Celecoxib | 78 | $2,124 | $27 |
| Prednisone | 158 | $1,721 | $11 |
| Alendronate | 127 | $1,556 | $12 |
| Gabapentin | 73 | $1,023 | $14 |
| Colchicine | 15 | $821 | $55 |
| Hydrocodone-Acetaminophen | 26 | $691 | $27 |
| Risedronate | 12 | $549 | $46 |
| Meloxicam | 41 | $402 | $10 |
| Sulfasalazine | 13 | $349 | $27 |
| Allopurinol | 26 | $327 | $13 |
| Folic Acid | 30 | $265 | $9 |
| Duloxetine | 14 | $202 | $14 |
| Cyclobenzaprine | 12 | $133 | $11 |
| Amlodipine Besylate | 13 | $36 | $3 |
| Lorazepam | 11 | $22 | $2 |
Year by year
| 2024 | 1,412 | 238 | 4% (49) | None | $2,193,608 |
| 2023 | 1,379 | 246 | 2% (26) | None | $2,399,229 |
| 2022 | 1,423 | 255 | 4% (57) | None | $1,733,308 |
| 2021 | 1,507 | 263 | 6% (92) | None | $1,497,838 |
| 2020 | 1,430 | 247 | 5% (64) | None | $1,299,450 |
| 2019 | 1,318 | 249 | 5% (62) | None | $1,330,903 |
| 2018 | 1,229 | 220 | 9% (113) | None | $794,923 |
| 2017 | 1,305 | 215 | 10% (135) | None | $686,891 |
| 2016 | 1,351 | 213 | 10% (135) | 22% | $451,266 |
| 2015 | 1,447 | 201 | 10% (143) | None | $333,858 |
| 2014 | 1,225 | 167 | 13% (160) | 22% | $218,830 |
| 2013 | 1,112 | 142 | 15% (162) | None | $205,486 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 18 drugs
| Humira(Cf) | 122 | $1,332,364 | $10,921 |
| Rinvoq | 39 | $304,628 | $7,811 |
| Simponi | 12 | $78,253 | $6,521 |
| Tymlos | 12 | $32,939 | $2,745 |
| Hydroxychloroquine Sulfate | 248 | $20,803 | $84 |
| Methotrexate | 136 | $7,614 | $56 |
| Celecoxib | 42 | $3,398 | $81 |
| Leflunomide | 42 | $3,137 | $75 |
| Febuxostat | 15 | $2,837 | $189 |
| Colchicine | 20 | $2,234 | $112 |
| Alendronate | 117 | $1,907 | $16 |
| Prednisone | 152 | $1,608 | $11 |
| Gabapentin | 64 | $853 | $13 |
| Sulfasalazine | 28 | $754 | $27 |
| Allopurinol | 21 | $554 | $26 |
| Meloxicam | 30 | $388 | $13 |
| Pantoprazole | 15 | $352 | $23 |
| Folic Acid | 42 | $200 | $5 |
2022: 24 drugs
| Humira(Cf) | 97 | $950,474 | $9,799 |
| Rinvoq | 26 | $195,078 | $7,503 |
| Enbrel Sureclick | 16 | $102,781 | $6,424 |
| Taltz | 12 | $86,845 | $7,237 |
| Enbrel | 12 | $83,591 | $6,966 |
| Hydroxychloroquine Sulfate | 230 | $22,625 | $98 |
| Methotrexate | 158 | $10,788 | $68 |
| Colchicine | 27 | $5,081 | $188 |
| Leflunomide | 30 | $4,171 | $139 |
| Febuxostat | 20 | $3,827 | $191 |
| Mycophenolate Mofetil | 18 | $3,406 | $189 |
| Celecoxib | 49 | $3,367 | $69 |
| Prednisone | 171 | $2,427 | $14 |
| Alendronate | 150 | $1,994 | $13 |
| Gabapentin | 43 | $1,206 | $28 |
| Allopurinol | 22 | $652 | $30 |
| Sulfasalazine | 23 | $647 | $28 |
| Oxycodone-Acetaminophen | 12 | $448 | $37 |
| Pantoprazole | 13 | $308 | $24 |
| Folic Acid | 51 | $265 | $5 |
| Meloxicam | 30 | $171 | $6 |
| Ibuprofen | 18 | $164 | $9 |
| Hydrocodone-Acetaminophen | 12 | $156 | $13 |
| Tramadol Hcl-Acetaminophen | 11 | $57 | $5 |
2021: 29 drugs
| Humira(Cf) | 73 | $793,708 | $10,873 |
| Enbrel Sureclick | 20 | $117,778 | $5,889 |
| Cosentyx Pen (2 Pens) | 13 | $78,584 | $6,045 |
| Enbrel | 12 | $75,199 | $6,267 |
| Forteo | 13 | $73,087 | $5,622 |
| Hydroxychloroquine Sulfate | 276 | $26,236 | $95 |
| Methotrexate | 160 | $10,369 | $65 |
| Colchicine | 26 | $5,743 | $221 |
| Mycophenolate Mofetil | 15 | $4,091 | $273 |
| Febuxostat | 27 | $3,851 | $143 |
| Leflunomide | 20 | $3,413 | $171 |
| Prednisone | 235 | $3,088 | $13 |
| Alendronate | 134 | $1,796 | $13 |
| Celecoxib | 32 | $1,288 | $40 |
| Gabapentin | 56 | $1,026 | $18 |
| Hydrocodone-Acetaminophen | 22 | $708 | $32 |
| Oxycodone-Acetaminophen | 12 | $643 | $54 |
| Sulfasalazine | 20 | $599 | $30 |
| Acetaminophen-Codeine | 12 | $561 | $47 |
| Diclofenac | 14 | $400 | $29 |
| Ibuprofen | 21 | $379 | $18 |
| Cyclobenzaprine | 12 | $323 | $27 |
| Allopurinol | 14 | $297 | $21 |
| Pregabalin | 11 | $287 | $26 |
| Tramadol | 23 | $148 | $6 |
| Folic Acid | 30 | $143 | $5 |
| Meloxicam | 19 | $130 | $7 |
| Hydromorphone | 17 | $98 | $6 |
| Lorazepam | 11 | $36 | $3 |
2020: 27 drugs
| Humira(Cf) | 54 | $582,734 | $10,791 |
| Enbrel | 17 | $87,825 | $5,166 |
| Enbrel Sureclick | 16 | $87,585 | $5,474 |
| Xeljanz Xr | 14 | $79,590 | $5,685 |
| Humira | 12 | $65,703 | $5,475 |
| Hydroxychloroquine Sulfate | 282 | $33,716 | $120 |
| Methotrexate | 137 | $9,626 | $70 |
| Colchicine | 21 | $6,961 | $331 |
| Febuxostat | 18 | $5,067 | $282 |
| Leflunomide | 26 | $4,920 | $189 |
| Mycophenolate Mofetil | 16 | $4,154 | $260 |
| Prednisone | 222 | $3,181 | $14 |
| Diclofenac | 24 | $1,607 | $67 |
| Gabapentin | 50 | $1,448 | $29 |
| Alendronate | 112 | $1,336 | $12 |
| Celecoxib | 24 | $1,132 | $47 |
| Sulfasalazine | 26 | $896 | $34 |
| Hydrocodone-Acetaminophen | 24 | $613 | $26 |
| Acetaminophen-Codeine | 14 | $603 | $43 |
| Allopurinol | 29 | $492 | $17 |
| Pantoprazole | 13 | $307 | $24 |
| Omeprazole | 19 | $247 | $13 |
| Escitalopram | 15 | $109 | $7 |
| Meloxicam | 22 | $103 | $5 |
| Nortriptyline | 16 | $101 | $6 |
| Tramadol | 15 | $76 | $5 |
| Lorazepam | 14 | $34 | $2 |
2019: 26 drugs
| Humira(Cf) | 53 | $505,099 | $9,530 |
| Humira | 17 | $117,185 | $6,893 |
| Xeljanz Xr | 25 | $114,444 | $4,578 |
| Enbrel Sureclick | 17 | $89,029 | $5,237 |
| Forteo | 14 | $80,030 | $5,716 |
| Enbrel | 12 | $64,867 | $5,406 |
| Hydroxychloroquine Sulfate | 198 | $29,672 | $150 |
| Lyrica | 11 | $10,883 | $989 |
| Methotrexate | 126 | $7,735 | $61 |
| Colchicine | 21 | $7,713 | $367 |
| Leflunomide | 23 | $6,571 | $286 |
| Prednisone | 165 | $2,514 | $15 |
| Celecoxib | 39 | $1,454 | $37 |
| Gabapentin | 72 | $1,359 | $19 |
| Diclofenac | 23 | $1,296 | $56 |
| Alendronate | 89 | $1,155 | $13 |
| Sulfasalazine | 32 | $1,080 | $34 |
| Acetaminophen-Codeine | 14 | $577 | $41 |
| Allopurinol | 22 | $440 | $20 |
| Hydrocodone-Acetaminophen | 18 | $419 | $23 |
| Pantoprazole | 14 | $275 | $20 |
| Tramadol | 14 | $216 | $15 |
| Omeprazole | 23 | $215 | $9 |
| Meloxicam | 25 | $167 | $7 |
| Nortriptyline | 13 | $141 | $11 |
| Triamterene-Hydrochlorothiazid | 12 | $66 | $6 |
2018: 23 drugs
| Humira | 49 | $296,407 | $6,049 |
| Enbrel Sureclick | 18 | $89,173 | $4,954 |
| Humira(Cf) | 12 | $68,025 | $5,669 |
| Actemra | 11 | $61,917 | $5,629 |
| Hydroxychloroquine Sulfate | 213 | $38,266 | $180 |
| Methotrexate | 129 | $10,375 | $80 |
| Uloric | 14 | $9,711 | $694 |
| Colchicine | 17 | $8,292 | $488 |
| Leflunomide | 16 | $7,536 | $471 |
| Prednisone | 189 | $2,639 | $14 |
| Celecoxib | 22 | $1,676 | $76 |
| Diclofenac | 13 | $1,148 | $88 |
| Hydrocodone-Acetaminophen | 49 | $1,034 | $21 |
| Sulfasalazine | 28 | $1,024 | $37 |
| Alendronate | 74 | $843 | $11 |
| Allopurinol | 24 | $594 | $25 |
| Pantoprazole | 17 | $553 | $33 |
| Acetaminophen-Codeine | 20 | $417 | $21 |
| Gabapentin | 30 | $400 | $13 |
| Tramadol | 26 | $351 | $13 |
| Meloxicam | 18 | $300 | $17 |
| Omeprazole | 17 | $149 | $9 |
| Trazodone | 11 | $48 | $4 |
2017: 27 drugs
| Humira | 46 | $287,268 | $6,245 |
| Enbrel Sureclick | 21 | $121,878 | $5,804 |
| Forteo | 21 | $66,095 | $3,147 |
| Hydroxychloroquine Sulfate | 208 | $39,808 | $191 |
| Uloric | 21 | $12,386 | $590 |
| Methotrexate | 143 | $11,421 | $80 |
| Colchicine | 13 | $5,564 | $428 |
| Leflunomide | 13 | $5,473 | $421 |
| Prednisone | 176 | $3,152 | $18 |
| Cevimeline | 13 | $2,058 | $158 |
| Celecoxib | 34 | $1,931 | $57 |
| Diclofenac | 20 | $1,673 | $84 |
| Hydrocodone-Acetaminophen | 54 | $984 | $18 |
| Alendronate | 76 | $780 | $10 |
| Sulfasalazine | 31 | $683 | $22 |
| Acetaminophen-Codeine | 17 | $629 | $37 |
| Allopurinol | 22 | $583 | $26 |
| Tramadol | 33 | $433 | $13 |
| Oxycodone-Acetaminophen | 12 | $408 | $34 |
| Tramadol Hcl-Acetaminophen | 11 | $381 | $35 |
| Cyclobenzaprine | 28 | $372 | $13 |
| Meloxicam | 20 | $363 | $18 |
| Gabapentin | 21 | $249 | $12 |
| Pantoprazole | 19 | $237 | $12 |
| Triamterene-Hydrochlorothiazid | 16 | $233 | $15 |
| Omeprazole | 13 | $227 | $17 |
| Amlodipine Besylate | 12 | $80 | $7 |
2016: 26 drugs
| Humira | 23 | $129,828 | $5,645 |
| Enbrel | 28 | $106,872 | $3,817 |
| Forteo | 22 | $55,599 | $2,527 |
| Hydroxychloroquine Sulfate | 217 | $36,807 | $170 |
| Uloric | 22 | $10,033 | $456 |
| Methotrexate | 175 | $9,876 | $56 |
| Colchicine | 17 | $4,146 | $244 |
| Prednisone | 189 | $2,795 | $15 |
| Leflunomide | 14 | $2,345 | $167 |
| Celecoxib | 22 | $1,772 | $81 |
| Hydrocodone-Acetaminophen | 47 | $1,425 | $30 |
| Temazepam | 12 | $1,102 | $92 |
| Alendronate | 87 | $1,087 | $12 |
| Acetaminophen-Codeine | 29 | $745 | $26 |
| Diclofenac | 13 | $663 | $51 |
| Tramadol Hcl-Acetaminophen | 29 | $606 | $21 |
| Allopurinol | 35 | $490 | $14 |
| Mycophenolate Mofetil | 12 | $477 | $40 |
| Tramadol | 21 | $476 | $23 |
| Meloxicam | 45 | $430 | $10 |
| Trazodone | 15 | $369 | $25 |
| Pantoprazole | 23 | $348 | $15 |
| Omeprazole | 27 | $198 | $7 |
| Sulfasalazine | 21 | $153 | $7 |
| Lorazepam | 14 | $80 | $6 |
| Cyclobenzaprine | 17 | $48 | $3 |
2015: 28 drugs
| Humira | 29 | $92,309 | $3,183 |
| Enbrel | 21 | $68,860 | $3,279 |
| Hydroxychloroquine Sulfate | 188 | $32,738 | $174 |
| Methotrexate | 168 | $13,289 | $79 |
| Uloric | 29 | $11,912 | $411 |
| Lyrica | 21 | $5,609 | $267 |
| Colchicine | 34 | $5,175 | $152 |
| Celecoxib | 27 | $3,912 | $145 |
| Prednisone | 297 | $3,756 | $13 |
| Voltaren | 15 | $1,576 | $105 |
| Hydrocodone-Acetaminophen | 65 | $1,526 | $23 |
| Alendronate | 81 | $990 | $12 |
| Temazepam | 22 | $914 | $42 |
| Acetaminophen-Codeine | 21 | $544 | $26 |
| Duloxetine | 11 | $441 | $40 |
| Allopurinol | 35 | $437 | $12 |
| Tramadol Hcl-Acetaminophen | 26 | $428 | $16 |
| Gabapentin | 14 | $343 | $25 |
| Tramadol | 27 | $329 | $12 |
| Azathioprine | 16 | $326 | $20 |
| Eszopiclone | 11 | $317 | $29 |
| Sulfasalazine | 15 | $293 | $20 |
| Bisoprolol | 11 | $265 | $24 |
| Omeprazole | 19 | $179 | $9 |
| Pantoprazole | 23 | $173 | $8 |
| Meloxicam | 14 | $79 | $6 |
| Cyclobenzaprine | 18 | $62 | $3 |
| Nortriptyline | 12 | $43 | $4 |
2014: 25 drugs
| Humira | 28 | $100,677 | $3,596 |
| Prolia | 13 | $11,271 | $867 |
| Methotrexate | 144 | $9,553 | $66 |
| Uloric | 30 | $8,166 | $272 |
| Celebrex | 29 | $7,565 | $261 |
| Hydroxychloroquine Sulfate | 184 | $5,942 | $32 |
| Colcrys | 33 | $5,607 | $170 |
| Lidocaine | 14 | $3,012 | $215 |
| Hydrocodone-Acetaminophen | 101 | $2,488 | $25 |
| Prednisone | 218 | $2,477 | $11 |
| Voltaren | 11 | $912 | $83 |
| Alendronate | 61 | $838 | $14 |
| Gabapentin | 22 | $506 | $23 |
| Acetaminophen-Codeine | 27 | $491 | $18 |
| Tramadol | 16 | $255 | $16 |
| Azathioprine | 12 | $245 | $20 |
| Trazodone | 16 | $218 | $14 |
| Levothyroxine | 18 | $198 | $11 |
| Temazepam | 18 | $192 | $11 |
| Tramadol Hcl-Acetaminophen | 15 | $131 | $9 |
| Omeprazole | 13 | $126 | $10 |
| Diazepam | 16 | $84 | $5 |
| Nortriptyline | 15 | $74 | $5 |
| Cyclobenzaprine | 11 | $65 | $6 |
| Lorazepam | 13 | $56 | $4 |
2013: 21 drugs
| Humira | 34 | $110,212 | $3,242 |
| Enbrel | 11 | $25,968 | $2,361 |
| Prolia | 16 | $13,428 | $839 |
| Uloric | 51 | $10,892 | $214 |
| Methotrexate | 123 | $8,507 | $69 |
| Colcrys | 27 | $4,383 | $162 |
| Lyrica | 21 | $4,259 | $203 |
| Celebrex | 25 | $3,639 | $146 |
| Hydroxychloroquine Sulfate | 126 | $3,126 | $25 |
| Lunesta | 12 | $3,014 | $251 |
| Actonel | 14 | $2,957 | $211 |
| Prednisone | 180 | $1,865 | $10 |
| Hydrocodone-Acetaminophen | 91 | $1,786 | $20 |
| Alendronate | 55 | $688 | $13 |
| Tramadol | 45 | $472 | $10 |
| Acetaminophen-Codeine | 17 | $305 | $18 |
| Trazodone | 15 | $163 | $11 |
| Temazepam | 16 | $152 | $9 |
| Levothyroxine | 17 | $137 | $8 |
| Allopurinol | 18 | $130 | $7 |
| Cyclobenzaprine | 14 | $56 | $4 |
Money from drug and device companies
$62 in 2023
| 2023 | 2 | 2 | None | $62 |
| 2021 | 3 | 3 | None | $41 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
See all 2 published payments
| AbbVie | Meals · 2023-05-25 | Rinvoq | $27 |
| Amgen | Meals · 2023-03-23 | Enbrel | $35 |
See earlier years (2021)
2021: $41
| GlaxoSmithKline | Benlysta | $15 | 1 payment
|
| Amgen | None | $14 | 1 payment
|
| AbbVie | Rinvoq | $12 | 1 payment
|
Professional record
- NPI
- 1487720439
- Licence
- CA A46442California A46442: Current · expires 2027-07-31
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207RR0500X (207RR0500X)
- Mailing address
- 325 Distel Cir, Los Altos, CA, 94022
- NPI first listed
- 2006-11-28
- NPI last updated
- 2020-03-09
- NPI record certified
- 2020-03-09
This is when the NPI record was last certified, not a medical board exam.